DCF — COLLETON MEDICAL CENTER
Enterprise Value: $-144.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-144.7M
Enterprise Value
$-45.0M
PV of Cash Flows
$-99.7M
PV of Terminal Value
$-160.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $68.1M | $-9.4M | -14.0% | $-12.3M | $-11.2M |
| Year 2 | $70.1M | $-9.0M | -13.0% | $-12.0M | $-9.9M |
| Year 3 | $72.2M | $-8.6M | -12.0% | $-11.6M | $-8.7M |
| Year 4 | $74.4M | $-8.4M | -11.0% | $-11.6M | $-7.9M |
| Year 5 | $76.6M | $-8.5M | -11.0% | $-11.7M | $-7.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-144.7M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$66.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.14344327626061532
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5